Standout Papers

Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Act... 1997 2026 2006 2016 505
  1. Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus (1997)
    Syd Johnson, Cynthia N. Oliver et al. The Journal of Infectious Diseases

Immediate Impact

5 by Nobel laureates 17 from Science/Nature 60 standout
Sub-graph 1 of 24

Citing Papers

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants
2023 Standout
Respiratory syncytial virus infection and novel interventions
2023 Standout
10 intermediate papers

Works of J. E. O'GRADY being referenced

Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus
1997 Standout

Author Peers

Author Last Decade Papers Cites
J. E. O'GRADY 171 210 116 593 292 34 1.2k
Eduardo Alves Bambirra 164 165 267 215 174 67 1.2k
Aruna K. Behera 255 349 222 374 314 27 1.2k
Eskild Petersen 193 244 97 697 419 29 1.4k
R. C. Giles 230 100 71 228 134 36 1.0k
Giustina Vitale 292 87 65 234 205 29 879
B. O. Ikede 179 118 90 640 87 47 1.1k
Sophie Brun 87 79 178 644 482 53 1.4k
R. van Furth 167 471 220 352 304 41 1.4k
Maria da Glória Bonecini-Almeida 112 398 176 707 564 44 1.3k
Enrico Bollo 104 73 155 283 201 78 1.0k

All Works

Loading papers...

Rankless by CCL
2026